Inhibition of two imidazole antimycotics, eberconazole and clotrimazole, by different components of Candida albicans serotype B membrane protoplasts

Int J Antimicrob Agents. 1993 Jul;3(1):61-4. doi: 10.1016/0924-8579(93)90006-q.

Abstract

The inhibitory activity of different components from Candida albicans membrane protoplasts against clotrimazole and eberconazole was studied. The phospholipid fraction had the most inhibitory activity and the antimycotic activity of eberconazole was more affected than that of clotrimazole.